Major trial launches for First-Ever chikungunya vaccine
NCT ID NCT07467707
Summary
This is a large, late-stage study to test a new vaccine designed to prevent chikungunya, a painful mosquito-borne illness. It will enroll over 6,000 healthy adolescents and adults who have not had chikungunya before. The main goal is to see if the vaccine safely prevents people from getting sick with the disease compared to a placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHIKUNGUNYA VIRUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Kamphaeng Phet Provincial Hospital
Kamphaeng Phet, Changwat Kamphaeng Phet, 62000, Thailand
Contact
-
Songklanagarind hospital, Prince of Songkla University (PSU)
Hat Yai, Changwat Songkhla, 90110, Thailand
Contact
-
WRAIR-AFRIMS Philippines, Cebu (WRAIR-APC)
Cebu City, Cebu, 6000, Philippines
Contact
Conditions
Explore the condition pages connected to this study.